| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.45▲ | 1.46▼ | 1.45▲ | 1.47▼ | 1.36▲ |
| MA10 | 1.45▼ | 1.45▲ | 1.42▲ | 1.48▼ | 1.24▲ |
| MA20 | 1.46▼ | 1.42▲ | 1.43▲ | 1.34▲ | 1.19▲ |
| MA50 | 1.45▲ | 1.44▲ | 1.50▼ | 1.19▲ | 1.16▲ |
| MA100 | 1.42▲ | 1.50▼ | 1.41▲ | 1.20▲ | 2.04▼ |
| MA200 | 1.42▲ | 1.39▲ | 1.29▲ | 1.18▲ | 6.54▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.007▲ | 0.009▲ | 0.000▲ | 0.049▲ |
| RSI | 48.351▼ | 54.394▲ | 50.976▲ | 56.710▲ | 58.550▲ |
| STOCH | 18.333▼ | 74.914 | 83.867▲ | 48.010 | 72.133 |
| WILL %R | -71.429 | -22.727▲ | -19.231▲ | -44.545 | -32.930 |
| CCI | -33.786 | 51.852 | 83.333 | 11.067 | 135.539▲ |
|
Wednesday, March 04, 2026 11:06 AM
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...
|
|
Tuesday, March 03, 2026 01:19 PM
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...
|
|
Thursday, February 26, 2026 12:00 PM
Fate Therapeutics (NASDAQ: FATE) just disclosed its Q4 earnings on Thursday, February 26, 2026 at 04:00 PM. Here's a brief overview of the earnings report. Fate Therapeutics missed estimated earnings ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/03/26 | 1.40 | 1.48 | 1.365 | 1.45 | 1,366,246 |
| 03/03/26 | 1.45 | 1.45 | 1.332 | 1.37 | 1,445,562 |
| 02/03/26 | 1.41 | 1.515 | 1.41 | 1.50 | 1,177,537 |
| 27/02/26 | 1.55 | 1.60 | 1.44 | 1.48 | 1,596,620 |
| 26/02/26 | 1.46 | 1.58 | 1.3909 | 1.56 | 2,362,703 |
| 25/02/26 | 1.62 | 1.695 | 1.475 | 1.48 | 2,332,152 |
| 24/02/26 | 1.5099 | 1.67 | 1.4902 | 1.62 | 3,584,251 |
| 23/02/26 | 1.45 | 1.54 | 1.405 | 1.51 | 0 |
| 20/02/26 | 1.38 | 1.465 | 1.32 | 1.46 | 1,976,641 |
| 19/02/26 | 1.34 | 1.40 | 1.31 | 1.40 | 1,323,168 |
|
|
||||
|
|
||||
|
|